Alopecia Areata in a Patient Treated with Interferon Alpha-2a for Chronic Hepatitis B / 대한피부과학회지
Korean Journal of Dermatology
; : 40-43, 2014.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-87771
Biblioteca responsável:
WPRO
ABSTRACT
Recent studies recommend pegylated interferon alpha2a as the first choice treatment for chronic hepatitis B, especially when the patient is negative for HBeAg. Pegylated interferon alpha is known to show variable side effects including skin symptoms, with alopecia as the most common dermatologic side effect experienced for 10% up to 36%. pcc) Most alopecia cases related to pegylated interferon alpha were presented with telogen effluvium pattern, but alopecia areata cases are reported rarely. In this case, typically localized alopecia areata was presented with pegylated interferon alpha2a treatment in hepatitis B patient, and the course of alopecia areata seemed to be related with administration and discontinuation of pegylated interferon alpha2a.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pele
/
Interferons
/
Interferon-alfa
/
Hepatite B Crônica
/
Alopecia
/
Alopecia em Áreas
/
Hepatite B
/
Antígenos E da Hepatite B
/
Hepatite Crônica
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Ano de publicação:
2014
Tipo de documento:
Artigo